Integration of High Throughput ‘Omic Platforms into Antibody Discovery

Video   Dec 23, 2016

 

From antibodies to vaccines to T cells, cancer immunotherapy is extending patient lives. Targeted therapies using immune cell receptors can be targeted to either cancer or immune cells. In pursuit of lead structures, ‘omic technologies are revolutionizing the discovery and development of novel biological lead structures. However, ‘omic platforms are first and foremost data generation instruments that require careful integration into workflows. Here, we demonstrate how we have applied next-generation sequencing, big data, biostatistics, and computational immunology to the discovery and development of novel lead structures.

 
 
 
 

Recommended Videos

CellStream™ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

Do you want faster protein digestion?

Video

Obtain high quality analytical results from protein digests using Thermo Scientific™ SMART Digest™ Kits.

WATCH NOW

Hussein's Lifesaving Stem Cell Treatment

Video

How stem cell gene therapy helped save the life of a boy born with SCID.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy